Ownership history in BRAIDWELL LP · 12 quarters on record
This page tracks every 13F SEC filing in which BRAIDWELL LP reported a position in NEUROCRINE BIOSCIENCES INC (NBIX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 751,534 | -128,748 | -14.6% | 3.41% | $106.6M | $141.83 |
| 2025 Q3 | REDUCED | 880,282 | -280,143 | -24.1% | 3.67% | $123.6M | $140.38 |
| 2025 Q2 | REDUCED | 1,160,425 | -31,500 | -2.6% | 4.99% | $145.9M | $125.69 |
| 2025 Q1 | ADDED | 1,191,925 | +290,135 | +32.2% | 4.63% | $131.8M | $110.60 |
| 2024 Q4 | REDUCED | 901,790 | -15,884 | -1.7% | 3.65% | $123.1M | $136.50 |
| 2024 Q3 | ADDED | 917,674 | +158,665 | +20.9% | 3.00% | $105.7M | $115.22 |
| 2024 Q2 | ADDED | 759,009 | +28,800 | +3.9% | 3.28% | $104.5M | $137.67 |
| 2024 Q1 | ADDED | 730,209 | +15,000 | +2.1% | 3.25% | $100.7M | $137.92 |
| 2023 Q4 | REDUCED | 715,209 | -252,815 | -26.1% | 3.46% | $94.2M | $131.76 |
| 2023 Q3 | ADDED | 968,024 | +34,662 | +3.7% | 3.44% | $108.9M | $112.50 |
As of 2025 Q4 — sorted by position size